IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CNS Pharmaceuticals Inc (CNSP)

CUSIP: 18978H508 | NYSE | Healthcare · Biotechnology | Micro Cap | 20 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIkarian Capital, LLC147,2909.9%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/AIkarian Capital, LLC147,290
9.9% of class · Jun 30, 2026

Institutional Holders — Q3 2026

UBS Group AG130
0.0% of portfolio›$689
FMR LLC26
0.0% of portfolio›$136
Barrett & Company, Inc.8
0.0% of portfolio›$42
Barclays PLC1
0.0% of portfolio›$5
Danske Bank A/S1
0.0% of portfolio›$5
StyleTurnoverLocationFiled
UBS Group AG
130$6890.0%CoreMediumZurich, Switzerland2026-11-10
FMR LLC
26$1360.0%GrowthMediumBoston, MA2026-11-10
Barrett & Company, Inc.
8$420.0%ETFLowProvidence, RI2026-10-22
Barclays PLC
1$50.0%GrowthMediumLondon, United Kingdom2026-11-06
Danske Bank A/S
1$50.0%GrowthLowCopenhagen V, Greece2026-11-09
New 5%+ stake
No 13F filer matched